{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:12:13Z","timestamp":1791396733242,"version":"4.3.3"},"reference-count":84,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1517\/14656566.2014.947960","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T10:07:36Z","timestamp":1406887656000},"page":"1943-1953","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Sertindole in schizophrenia: efficacy and safety issues"],"prefix":"10.1517","volume":"15","author":[{"given":"Maria Rosaria Anna","family":"Muscatello","sequence":"first","affiliation":[{"name":"University of Messina, Department of Neurosciences, Section of Psychiatry","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bruno","sequence":"additional","affiliation":[{"name":"University of Messina, Department of Neurosciences, Section of Psychiatry","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Micali Bellinghieri","sequence":"additional","affiliation":[{"name":"University of Messina, Department of Neurosciences, Section of Psychiatry","place":["Italy"]},{"name":"University of Messina, Department of Experimental and Clinical Medicine","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pandolfo","sequence":"additional","affiliation":[{"name":"University of Messina, Department of Neurosciences, Section of Psychiatry","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco Antonio","family":"Zoccali","sequence":"additional","affiliation":[{"name":"Professor,University of Messina, Department of Neurosciences, Section of Psychiatry","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,8]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000291630"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61764-X"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.12.487"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001563"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr125"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.04.020"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000042"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.12.011"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.02.009"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110372548"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32834bbc0d"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500210340"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.13.1825"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.773971"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199702001-00005"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199803003-00011"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500215967"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418002-00003"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s7602"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.5.629"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S6591"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.536217"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.726984"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00112-7"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245352"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1578-4"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890100105"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100814"},{"key":"e_1_3_1_31_1","first-page":"25","article-title":"Parametric PET imaging of 5-HT2A receptor distribution with 18F-setoperone in the normal human cortex","volume":"40","author":"Petit-Tabou\u00e9 MC","year":"1999","unstructured":"Petit-Tabou\u00e9 MC, Landeau B, Barr\u00e9 L, et al. Parametric PET imaging of 5-HT2A receptor distribution with 18F-setoperone in the normal human cortex. J Nucl Med 1999;40:25-32","journal-title":"J Nucl Med"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1083-5"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.07.015"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<533::AID-BDD42>3.0.CO;2-J"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0437-9"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90063-1"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050278"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04287.x"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245618"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.6.782"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500050518406"},{"key":"e_1_3_1_42_1","first-page":"61","article-title":"Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia","volume":"34","author":"Daniel DG","year":"1998","unstructured":"Daniel DG, Wozniak P, Mack RJ, et al. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. Psychopharmacol Bull 1998;34:61-9","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328354dcda"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-16"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000177020.26311.a7"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.07m03733yel"},{"issue":"6","key":"e_1_3_1_47_1","first-page":"326","article-title":"The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study","volume":"27","author":"Kwon JS","year":"2012","unstructured":"Kwon JS, Mittoux A, Hwang JY, et al. The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study. Int Clin Psychopharmacol 2012;27(6):326-35","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318248dfb8"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301654"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1132-9"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0774-3"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1540-5"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1702-5"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2011.06.011"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2487-x"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-990291"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.07.015"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111415734"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2012.01840.x"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125313499065"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418002-00003"},{"issue":"3","key":"e_1_3_1_63_1","first-page":"CD001715","article-title":"Sertindole for schizophrenia","author":"Lewis R","year":"2005","unstructured":"Lewis R, Bagnall AM, Leitner M. Sertindole for schizophrenia. Cochrane Database Syst Rev 2005(3):CD001715","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-010-0142-x"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.11.001"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2000.03337.x"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651500215969"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.64"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.04.011"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01534.x"},{"key":"e_1_3_1_71_1","unstructured":"Hertz S. NDA file. 2010. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrug Safety Information for Patients and Providers\/UCM234349.pdf"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500212"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1425"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0018-0"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-57"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2010.01563.x"},{"key":"e_1_3_1_77_1","first-page":"47","article-title":"Mortality rates in three comparative cohorts of patients who received sertindole, olanzapine or risperidone: a hospital-based, retrospective study","volume":"10","author":"Muldoon C","year":"2006","unstructured":"Muldoon C, Cochran J. Mortality rates in three comparative cohorts of patients who received sertindole, olanzapine or risperidone: a hospital-based, retrospective study. J Outcomes Res 2006;10:47-55","journal-title":"J Outcomes Res"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.09.001"},{"issue":"2","key":"e_1_3_1_79_1","first-page":"S79","article-title":"Cost-effectiveness of sertindole versus olanzapine or haloperidol: a comprehensive model","volume":"2","author":"Launois R","year":"1998","unstructured":"Launois R, Graf von der Schulenburg MG, Knapp M, Toumi M. Cost-effectiveness of sertindole versus olanzapine or haloperidol: a comprehensive model. Int J Psychiatry Clin Pract 1998;2(Suppl 2):S79-86","journal-title":"Int J Psychiatry Clin Pract"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2011.590603"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0107-9"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.143"},{"key":"e_1_3_1_83_1","volume-title":"Sertindole: summary of product characteristics","author":"H. Lundbeck A\/S","year":"2005","unstructured":"H. Lundbeck A\/S. Sertindole: summary of product characteristics. H. Lundbeck A\/S, Copenhagen; 2005"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(90)90038-9"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1954-0"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2014.947960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:49:09Z","timestamp":1770389349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2014.947960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":84,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1517\/14656566.2014.947960"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2014.947960","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}